Literature DB >> 30946244

Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma.

Stefano Partelli, Domenico Tamburrino, Rim Cherif, Francesca Muffatti, Elisabetta Moggia1, Sébastien Gaujoux, Alain Sauvanet2, Massimo Falconi, Giuseppe Fusai1.   

Abstract

OBJECTIVES: Pancreaticoduodenectomy (PD) is associated with a high risk of postoperative complications and mortality. The aim of this study was to compare postoperative morbidity after PD in patients undergoing resections for pancreatic neuroendocrine neoplasms (PanNENs) with patients undergoing the same resection for pancreatic ductal adenocarcinoma (PDAC).
METHODS: Data of 566 patients from 3 European tertiary referral centers between 1998 and 2014 were considered.
RESULTS: Overall, 566 patients (179 with PanNENs, 387 with PDAC) who underwent PD were analyzed. Patients with PanNENs were significantly younger (56 vs 64 years, P < 0.0001). The consistency of the pancreas was soft in 147 patients (82%) with PanNENs and in 162 patients (42%) with PDAC (P < 0.0001). Patients in the PanNENs group had a significantly higher rate of pancreatic fistula (P < 0.0001), bile leak (P = 0.004), abdominal collection (P = 0.017), and development of sepsis (P = 0.042). No differences in terms of overall postoperative complications, median length of stay, and in-hospital mortality were found. On multivariate analysis sex (male), PanNENs indication, blood transfusion, and a soft pancreatic texture were independent predictors of pancreatic fistula after PD.
CONCLUSIONS: Pancreaticoduodenectomy for PanNENs is associated with higher rate of surgical-specific postoperative complications than those for PDAC.

Entities:  

Mesh:

Year:  2019        PMID: 30946244     DOI: 10.1097/MPA.0000000000001273

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

Review 1.  How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery.

Authors:  Francesca Fermi; Valentina Andreasi; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Stefano Partelli; Massimo Falconi
Journal:  Curr Oncol Rep       Date:  2022-01-25       Impact factor: 5.075

2.  Vater's ampullary carcinoma increases the risk of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy: A retrospective and propensity score-matched analysis.

Authors:  Yifei Yang; Xu Fu; Saisai Zhu; Zhenghua Cai; Yudong Qiu; Liang Mao
Journal:  BMC Gastroenterol       Date:  2022-02-06       Impact factor: 3.067

3.  Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.

Authors:  Hallbera Gudmundsdottir; Ron Pery; Rondell P Graham; Cornelius A Thiels; Susanne G Warner; Rory L Smoot; Mark J Truty; Michael L Kendrick; Thorvardur R Halfdanarson; Elizabeth B Habermann; David M Nagorney; Sean P Cleary
Journal:  Ann Surg Oncol       Date:  2022-06-22       Impact factor: 4.339

4.  Microscopic transduodenal excision of an ampullary adenoma: A case report and review of the literature.

Authors:  Xiang Zheng; Qing-Jing Sun; Bo Zhou; Ming Jin; Sheng Yan
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.